Antiphospholipid syndrome is an important autoimmune disorder that affects normal blood clotting and increases the tendency for thrombosis. Although it is widely known for its vascular complications, its impact on the nervous system is equally significant and, in many cases, may represent the first manifestation of the disease.

Early recognition of neurological symptoms can prevent serious complications and lead to a more effective therapeutic approach.

What is Antiphospholipid Syndrome?

Antiphospholipid syndrome is characterized by the production of abnormal antibodies that disrupt the normal balance of blood coagulation. As a result, the body develops an increased tendency to form blood clots, which can affect various organs, including the brain.

The condition may occur as a primary disorder or in association with other autoimmune diseases, making its diagnosis more complex and demanding.

How Does It Affect the Nervous System?

The brain relies heavily on stable and adequate blood flow. Even small disturbances in circulation can lead to functional or structural damage. In the context of antiphospholipid syndrome, thromboses—whether large or microscopic—can lead to a wide range of neurological manifestations.

Neurological Manifestations of the Syndrome

The most serious complication is stroke, which can occur even in young individuals without obvious risk factors. In some cases, transient ischemic attacks (TIAs) may precede it, acting as an early warning sign of a future stroke.

At the same time, many patients report persistent headaches or migraines, which may represent an early manifestation of the condition. Microvascular damage in the brain can also lead to seizures or to milder but troubling symptoms such as memory impairment and difficulties with concentration.

It is not uncommon for the syndrome to present with psychiatric symptoms, including anxiety, depressive mood, or behavioral changes. In rarer cases, movement disorders such as chorea may occur, characterized by involuntary and irregular movements.

When Should Evaluation Be Considered?

The presence of unexplained neurological symptoms, particularly in young individuals or in patients with recurrent episodes, should raise suspicion of antiphospholipid syndrome. The association between thrombotic events and neurological manifestations is a key element that should not be overlooked.

Diagnosis

Diagnosis is based on a combination of clinical findings and specialized blood tests. The detection of specific antibodies, such as anticardiolipin antibodies and lupus anticoagulant, constitutes a fundamental diagnostic criterion. However, confirmation of the condition requires repeat testing over time.

Therapeutic Approach

Treatment focuses primarily on the prevention of thrombosis. Anticoagulant therapy is the cornerstone of management and is tailored according to each patient’s history and individual needs. In some cases, a more specialized approach may be required, particularly when other autoimmune diseases coexist.

Neurological follow-up is equally important, as it allows for early detection of new symptoms and timely adjustment of treatment.

Antiphospholipid syndrome is a multisystem disease with significant neurological implications. Its manifestations can range from mild cognitive difficulties to severe vascular events.

Early diagnosis and appropriate management can significantly reduce the risk of complications and improve patients’ quality of life. For this reason, awareness and clinical vigilance remain essential.